Diabetes stocks are surprise winners from Novo Nordisk’s Wegovy study, analysts say
November 13, 2023 at 12:45 PM EST
Eli Lilly also scores, analysts say, as trial results leave door open for Zepbound to top Wegovy’s benefits.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
San Anselmo | San Anselmo News | San Anselmo Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|